The considerable involvement of TRPM7 in pathophysiological processes that are common to ME/CFS therefore suggest that this protein may represent a valuable therapeutic target to ameliorate disease burden in this disorder. Here, TRPM7 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.